1. Home
  2. CALC vs YCBD Comparison

CALC vs YCBD Comparison

Compare CALC & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$0.67

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Logo cbdMD Inc.

YCBD

cbdMD Inc.

HOLD

Current Price

$0.84

Market Cap

9.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CALC
YCBD
Founded
2011
2015
Country
United States
United States
Employees
N/A
42
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7M
9.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CALC
YCBD
Price
$0.67
$0.84
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$10.00
$2.00
AVG Volume (30 Days)
145.5K
2.2M
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$12.70
Revenue Next Year
N/A
$7.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$0.48
52 Week High
$7.20
$2.56

Technical Indicators

Market Signals
Indicator
CALC
YCBD
Relative Strength Index (RSI) 51.50 53.25
Support Level $0.50 $0.63
Resistance Level $0.78 $1.05
Average True Range (ATR) 0.05 0.14
MACD 0.02 -0.00
Stochastic Oscillator 80.36 26.27

Price Performance

Historical Comparison
CALC
YCBD

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.

About YCBD cbdMD Inc.

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Share on Social Networks: